Invention Grant
- Patent Title: GM-CSF variants and methods of use
-
Application No.: US15616216Application Date: 2017-06-07
-
Publication No.: US10562948B2Publication Date: 2020-02-18
- Inventor: Thomas Rutkoski , Alexey Teplyakov , Nicole Wunderler
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Eric Dichter
- Main IPC: C07K14/535
- IPC: C07K14/535 ; A61K38/19 ; A61K45/06

Abstract:
GM-CSF variants, polynucleotides encoding them, and methods of making and using the foregoing are useful in treatment of immune-related disorders, such as inflammatory bowel disease (IBD).
Public/Granted literature
- US20170355742A1 GM-CSF Variants and Methods of Use Public/Granted day:2017-12-14
Information query
IPC分类: